Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-12-09

Clinical Trial Update: Evaluating the Role of IGF-1 and S-Klotho In Plaque Phenotype and Vulnerability: the VISION Study.

View source ↗

Summary

The VISION study is evaluating the roles of IGF-1 and soluble Klotho in plaque phenotype and vulnerability in ischemic heart disease and chronic coronary syndro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IGF-1 (insulin-like growth factor 1)
  • S-Klotho (soluble Klotho protein)

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Ischemic Heart Disease, Chronic Coronary Syndrome | Status: ACTIVE_NOT_RECRUITING